earnings digest health barr pharmaceuticals inc barr pharmaceuticals inc shares fell as the drug maker reported a fiscal second quarter net loss weighed down by charges related to its october acquisition of croatias pliva dd and it forecast earnings and revenue below wall street expectations shares of the woodcliff lake n j maker of branded and generic drugs were down &# or at &# in p m composite trading yesterday on the new york stock exchange barr succeeded in buying pliva in october prevailing in a takeover battle with actavis group hf of iceland part of a broader move by generic drug makers to expand their global reach while making use of lower cost manufacturing capabilities barr projects adjusted per share earnings of &# to &# analysts surveyed by thomson financial have forecast on average &# a share 
